Home » Market News » DirectorsTalk Highlights » Good news if you can stomach them: Brussels sprouts could cut your risk of cancer!
Evgen Pharma Plc

Good news if you can stomach them: Brussels sprouts could cut your risk of cancer!

There is perhaps nothing more divisive at Christmas lunch than Brussels sprouts. They are the Marmite of the vegetable world, you either love them or hate them.

But increasingly, research suggests a taste for sprouts might be something that you should try to acquire.

They might not have achieved the buzz of say, blueberries or avocados, but they are arguably better for you.

‘I always say Brussels sprouts are for life not just for Christmas — or they should be because they are so good for you,’ says Catherine Collins, of the British Dietetic Association, and an NHS dietitian in Surrey. ‘They are a nutritional nugget we overlook because they are perceived as not being very glamorous.

Evgen Pharma PLC (LON:EVG) is a clinical stage drug development company focused on cancer and neurological disease. Their pipeline is based on their proprietary Sulforadex® technology, and includes a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane. 

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.